☰

Gary Koch

Affiliations: 
University of North Carolina, Chapel Hill, Chapel Hill, NC 
Area:
Biostatistics Biology, Statistics
Google:
"Gary Koch"
Tree Publications Similar researchers PubMed Report error

Parents

Sign in to add mentor

Children

Sign in to add trainee
Rebekkah S. Dann grad student 2006 UNC Chapel Hill
Michael A. Hussey grad student 2013 UNC Chapel Hill

Collaborators

Sign in to add collaborator
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Sui J, Jiao J, Sun Y, et al. (2020) Evaluation of alternative confidence intervals to address non-inferiority through the stratified difference between proportions. Pharmaceutical Statistics
Yu J, Koch G. (2020) Randomization-Based Methods for Treatment Comparisons for Dichotomous Outcomes for Multiple Anatomical Regions Statistics in Biopharmaceutical Research. 1-7
Ouyang J, Zhang P, Carroll KJ, et al. (2019) Comparisons of global tests on intersection hypotheses and their application in matched parallel gatekeeping procedures. Journal of Biopharmaceutical Statistics. 1-14
Wiener LE, Ivanova A, Li S, et al. (2019) Randomization-based analysis of covariance for inference in the sequential parallel comparison design. Journal of Biopharmaceutical Statistics. 1-18
Wang D, Robieson W, Zhao J, et al. (2019) Statistical considerations in a delayed-start design to demonstrate disease modification effect in neurodegenerative disorders. Pharmaceutical Statistics
Cotter O, Davison BA, Koch G, et al. (2019) 4329Mega-studies in heart failure, effect dilution in examination of new therapies European Heart Journal. 40
George DJ, Pantuck AJ, Motzer RJ, et al. (2018) S-TRAC trial: Sensitivity analyses of disease-free survival (DFS). Journal of Clinical Oncology. 36: 633-633
Torres VE, Chapman AB, Devuyst O, et al. (2017) Tolvaptan in Later-Stage Autosomal Dominant Polycystic Kidney Disease. The New England Journal of Medicine
Ouyang J, Carroll KJ, Koch G, et al. (2017) Coping with missing data in phase III pivotal registration trials: Tolvaptan in subjects with kidney disease, a case study. Pharmaceutical Statistics
Lam D, Koch GG, Preisser JS, et al. (2017) Randomization-based adjustment of multiple treatment hazard ratios for covariates with missing data. Journal of Biopharmaceutical Statistics. 1-14
See more...